Brian S. Tyler has been the CEO of McKesson Corporation since April 2019, taking over during a critical time for the company as it dealt with opioid litigation. Before becoming CEO, he held several key positions at McKesson, including President...
Brian S. Tyler has been the CEO of McKesson Corporation since April 2019, taking over during a critical time for the company as it dealt with opioid litigation. Before becoming CEO, he held several key positions at McKesson, including President of U.S. Pharmaceutical and Chief Operating Officer for McKesson Europe. He's been with the company since 2012, which shows his deep understanding of the business. Under his leadership, McKesson has focused on aligning with its shareholders' values, especially in sustainability and responsible engagement. Tyler's approach to compensation reflects McKesson's pay-for-performance philosophy; in 2023, his compensation was around $18.5 million, a sign that he is focused on the long-term success of the company. His previous roles in the company's structure have allowed him to shape strategy effectively, especially during trying times like the pandemic. In 2022, significant challenges led to compensation reductions, but Tyler still managed to earn around $20 million the previous year. He believes in listening to shareholders and adapting based on their feedback. This responsiveness is crucial in the health care sector where regulations and public perception matter greatly. Overall, Brian Tyler's journey with McKesson illustrates his commitment and ability to navigate complex challenges while pushing for growth and improvement in health outcomes for communities.